NCT03859492View on ClinicalTrials.gov

Screening CEDM in Intermediate and High-Risk Patient Populations

NACompletedINTERVENTIONAL
Enrollment

461

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Breast Cancer
Interventions
DEVICE

Contrast Enhanced Digital Mammography

High-resolution, low-energy, full-field digital mammography (FFDM) image and contrast-enhanced image

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03859492 - Screening CEDM in Intermediate and High-Risk Patient Populations | Biotech Hunter | Biotech Hunter